An approvable letter is sent by the FDA when a drugmaker's New Drug Application is not sufficient for approval, but has the potential to be approved at a later date. The letter spells out what problems the FDA had with the marketing application. Often times further meetings with the FDA are required to determine what needs to be done to get the drug approved.
Recent Mentions on Fool.com
- Bristol-Myers Squibb Finally Hits a Roadblock
- These Biotech Stocks Could Face a Cash Crunch in 2016
- iRobot Corporation Is Right to Resist This Mountain of Change
- Why Are Comcast's Data Cap Exemptions Evil If T-Mobile's Are A-OK?
- Gilead Sciences Grabs 4 Regulatory Wins -- but Does It Matter?
- 5 Things Pfizer Inc. Wants You to Know